EUVIMEDEUVIMED entdecken
Crossref

Subunit vaccine raised against the SARS‐CoV‐2 spike of Delta and Omicron variants

Sheng Feng iD, Zechang Fan, Keyue Zhou, Shanshan Ma, Mingzheng Liang, He Zhang, Yubiao Xie, Zhuo Ha, Ningyi Jin, Huijun Lu

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.29160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Sheng Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccination has proven effective against SARS‐CoV‐2 infection but vaccines were originally based on the wild type and emerging variants have led to a decrease in protective efficacy. There is an urgent need for broad‐spectrum vaccine protection against emerging variants. A vaccine based on the Delta strain spike protein was created by optimization of vector, codon, and protein structure to produce a subunit immunogen (Delta‐6P‐S) containing six proline mutations, stable pre‐fusion conformation, and with high expression in CHO‐S cells. Immunogenicity and protective efficacy were evaluated in mice and golden hamsters using alum adjuvant. The Delta‐6P‐S recombinant protein induced strong immune responses in C57BL/6J mice and golden hamsters and sera had cross‐neutralization activity and neutralized wild type and Beta, Delta, Omicron BA.1, BA.2, and BA.5 variant strains. Golden hamsters were immunized against Delta, Omicron BA.1, and BA.2 variants. Viral RNA detected from throat swabs, lungs and tracheas decreased significantly in vaccine‐inoculated animals relative to alum‐treated controls and no infectious viruses were detected in lungs and tracheas. Almost no pathological damage to lung tissue was found in vaccinated animals by contrast with those treated only with alum. The Delta‐6P‐S recombinant protein rapidly eliminated replicating virus in the upper and lower airways of golden hamsters and merits further investigation as a candidate anti‐SARS‐CoV‐2 vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19CricetinaeAnimalsMiceMice, Inbred C57BLMesocricetusVaccines, SubunitRecombinant ProteinsAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, CoronavirusAlum Compounds

Stichwörter der Autor:innen

DeltaOmicroncross-neutralization activityprotective efficacyrecombinant protein

Substanzen

Vaccines, SubunitRecombinant ProteinsAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusaluminum sulfateAlum Compoundsspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
  • College of Animal Science and Technology, Jilin Agricultural University, Changchun, China.
  • Beijing Northland Biotechnology Co., Ltd, Beijing, China.

ORCID-Profile: Sheng Feng

Zitieren

APA

Feng, S., Fan, Z., Zhou, K., Ma, S., Liang, M., Zhang, H., Xie, Y., Ha, Z., Jin, N., & Lu, H. (2023). Subunit vaccine raised against the SARS‐CoV‐2 spike of Delta and Omicron variants. Journal of Medical Virology. https://doi.org/10.1002/jmv.29160

Vancouver

Feng S, Fan Z, Zhou K, Ma S, Liang M, Zhang H, et al. Subunit vaccine raised against the SARS‐CoV‐2 spike of Delta and Omicron variants. Journal of Medical Virology. 2023. doi:10.1002/jmv.29160

BibTeX
@article{Feng2023,
  author = {Feng, Sheng and Fan, Zechang and Zhou, Keyue and Ma, Shanshan and Liang, Mingzheng and Zhang, He and Xie, Yubiao and Ha, Zhuo and Jin, Ningyi and Lu, Huijun},
  title = {Subunit vaccine raised against the SARS‐CoV‐2 spike of Delta and Omicron variants},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.29160}
}
Kostenlos starten →